Open Orphan

About:

A CRO pharma services group which is a world leader in testing of vaccines and antivirals through the use of human challenge clinical trials

Website: https://www.openorphan.com

Twitter/X: OpenOrphan

Top Investors: Raglan Capital

Description:

Open Orphan Open Orphan is a rapidly growing niche CRO pharmaceutical services group which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Conducted from Europe's only 24-bedroom quarantine clinic with onsite virology providing individually isolated rooms and connected to our specialist laboratory facility. Which offers highly specialised virology and immunology laboratory services to support pre-clinical and clinical respiratory drug, antiviral, and vaccine discovery and development.